p53 Mutations, polymorphisms, and haplotypes in Pakistani ethnic groups and breast cancer patients

Genetic Testing

Volumn 4, Issue 1, 2000, Pages 23-29

  Khaliq, S ^a   Hameed, A ^a   Khaliq, T ^b   Ayub, Q ^a   Qamar, R ^a   Mohyuddin, A ^a   Mazhar, K ^a   Mehdi, S Qasim ^a  

^a Dr A Q Khan Research Laboratories   (Pakistan)

^b PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; DNA SEQUENCE; ETHNIC GROUP; EXON; GENE FREQUENCY; GENE MUTATION; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTRON; PAKISTAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION SITE; TUMOR SUPPRESSOR GENE;

ALLELES; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; PAKISTAN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034006186     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065700316435     Document Type: Article

References (42)

1. AHMAD, M., KHAN, A.H., and MANSOOR, A. (1991). The pattern of malignant tumours in northern Pakistan. J. Pak. Med. Assoc. 11, 270-273.
2. BECKMAN, G., BIRGANDER, R., SJÄLANDER, A., SAHA, N., HOLMBERG, P.A., KIVELÄ, A., and BECKMAN, L. (1994). Is p53 polymorphism maintained by natural selection? Hum. Hered. 44, 266-270.
3. BELLEW, H.W. (1979). The Races of Afghanistan. (Sang-e-Meel Publications, Lahore.
4. BIDDULPH, J. (1977). Tribes of the Hindoo Koosh. (Indus Publications, Karachi).
5. BIRGANDER, R., SJÄLANDER, A., SAHA, N., SPITSYN, V., BECKMAN, L., and BECKMAN, G. (1996). The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups. Hum. Hered. 46, 148-154.
6. BOSARI, S., MARCHETTI, A., BUTTITTA, F., GRAZIANI, D., BORSANI, G., LODA, M., BEVILACQUA, G., and COGGI, G. (1995). Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver-stained SSCP analysis. Diagn. Mol. Pathol. 4, 249-255.
7. CHANG, F., SYRJÄNEN, S., KURVINEN, K., and SYRJÄNEN, K. (1993). The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am. J. Gastroentrol. 88, 174-186.
8. DE VRIES, E.M.G., RICKE, D.O., DE VRIES, T.N., HARTMANN, A., BLASZYK, H., LIAO, D., SOUSSI, T., KOVACH, J.S., and SOMMER, S.S. (1996). Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses. Hum. Mutat. 7, 202-213.
9. DENG, G., CHEN, L-C., SCHOTT, D.R., THOR, A., BHARGAVA, V., LJUNG, B-M., CHEW, K., and SMITH, H.S. (1994). Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res. 54, 499-505.
10. EVAN, G., and LITTLEWOOD, T. (1998). A matter of life and death. Science 281, 1317-1322.
11. FEARON, E.R. (1997). Human cancer syndromes: clues to the origin and nature of cancer. Science 278, 1043-1050.
12. GILLILAND, F.D. (1997). Ethnic differences in cancer incidence: a marker for inherited susceptibility? Environ. Health Perspect. 105, 4897-4900.
13. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C. (1994). Mutations in the p53 tumor suppressor gene:clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
14. HAINAUT, P., and HOLLSTEIN, M. (2000). p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res. 77, 81-137.
15. HAINAUT, P., HERNANDEZ, T., ROBINSON, A., RODRIGUEZ-TOME, P., FLORES, T., HOLLSTEIN, M., HARRIS, C.C., and MONTESANO, R. (1998). IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualization tools. Nucleic Acids Res. 26, 205-213.
16. HARTMANN, A., BLASZYK, H., KOVACH, J.S., and SOMMER, S.S. (1997). The molecular epidemiology of P53 gene mutations in human breast cancer. Trends Genetics 13, 27-33.
17. HERNANDEZ-BOUSSARD, T., RODRIGUEZ-TOME, P., MONTESANO, R., and HAINAUT, P. (1999). IARC p53 mutation database: a regional database to compile and analyze p53 mutations in human tumors and cell lines. Hum. Mutat. 14, 1-8.
18. HULKA, B.S. (1996). Epidemiology of susceptibility to breast cancer. Prog. Clin. Biol. Res. 395, 159-174.
19. KHALIQ, S., YOUNUS, F., SHEIKH, F.R., and MEHDI, S.Q. (1990). Analysis of the cell surface receptors of lectin stimulated and virus transformed human lymphocytes. Pak. J. Med. Res. 29, 25-28.
20. KOVACH, J.S., HARTMANN, A., BLASZYK, H., CUNNINGHAM, J., SCHAID, D., and SOMMER, S.S. (1996). Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc. Natl. Acad. Sci. USA 93, 1093-1096.
21. KRIEGER, N., WOLFF, M.S., HIATT, R.A., RIVERA, M., VOGELMAN, J., and ORENTREICH, N. (1994). Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J. Natl. Cancer Inst. 86, 589-599.
22. KRIEGER, N., VAN DEN EEDEN, S.K., ZAVA, D., and OKAMOTO, A. (1997). Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco bay area. Ethn. Dis. 7, 137-149.
23. MCBRIDE, D.W., MERRY, D., and GIVOL, D. (1986). The gene for human p53 cellular tumor antigen is located on chromosome 17, short arm 17p13. Proc. Natl. Acad. Sci. USA 83, 130-134.
24. NEI, M. (1973). Analysis of gene diversity in subdivided populations. Proc. Natl. Acad. Sci. USA 70, 3321-3323.
25. NEI, M., TAJIMA, F., and TATENO, Y. (1983). Accuracy of estimated phylogenetic trees from molecular data. J. Mol. Evol. 19, 153-170.
26. OSBORNE, R.J., MERLO, G.R., MITSUDOMI, T., VENESIO, T., LISCIA, D.S., CAPPA, A.P.M., CHIBA, I., TAKAHASHI, T., NAU, M.M., CALLAHAN, R., and MINNA, J.D. (1991). Mutations in the p53 gene in primary human breast cancers. Cancer Res. 51, 6194-6198.
27. PERARA, F.P. (1997). Environment and cancer: who are susceptible? Science 278, 1068-1073.
28. + Y chromosomes. Hum. Biol. 71, 745-755.
29. RASOOL, M.I., MALIK, I.A., LUQMAN, M., KHALILULLAH, K., and KHAN, A.H. (1998). A comprehensive study of breast cancer. Pak. J. Med. Res. 37, 2-8.
30. ROBERTSON, G.S. (1974). The Kafirs of the Hindu-Kush. (Oxford University Press, Karachi).
31. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, vol. 3. (Cold Spring Harbor Laboratory Press, Cold Spring, Harbor, NY).
32. SJÄLANDER, A., BIRGANDER R., ATHLINM L., STENLING, R., RUTEGAåRD, J., BECKMAN, L., and BECKMAN, G. (1995a). P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 16, 1461-1464.
33. SJÄLANDER, A., BIRGANDER, R., KIVELÄ, A., and BECKMAN, G. (1995b). p53 polymorphisms and haplotypes in different ethnic groups. Hum. Hered. 5, 144-149.
34. SJÄLANDER, A., BIRGANDER, R., HALLMANS, G., CAJANDER, S., LENNER, P., ATHLIN, L., BECKMAN, G., and BECKMAN, L. (1996a). p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17, 1313-1316.
35. SJÄLANDER, A., BIRGANDER, R., SAHA, N., BECKMAN, L., and BECKMAN, G. (1996b). p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Hum. Hered. 46, 41-48.
36. STOREY, A., THOMAS, M., KALITA, A., HARWOOD, C., GARDIOL, D., MANTOVANI, F., BREUER, J., LEIGH, I.M., MATLASHEWSKI, G., and BANKS, L. (1998). Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer. Nature 393, 229-234.
37. STRAUSS, W.M. (1995). Preparation of genomic DNA from mammalian tissue. In Current Protocols in Molecular Biology, vol. 1 (F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, eds.), (John Wiley and Sons. Inc., Cambridge) pp. 2.2.1-2.2.3.
38. SUN, Y., KESHAVA, C., SHARP, D.S., WESTON, A., and McCANLIES E.C. (1999). DNA sequence variants of p53:cancer and aging. Am. J. Hum. Genet. 65, 1779-1782.
39. TERWILLIGER, J.D., and OTT, J. (1994). Handbook of Human Genetic Linkage. (John Hopkins University Press, Baltimore, MD).
40. THOMPSON, A.M., ANDERSON, T.J., CONDIE, A., PROSSER, J., CHETTY, U., CARTER, D.C., EVANS, H.J., and STEEL, C.M. (1992). p53 allele losses, mutations, and expression in breast cancer and their relationship to clinico-pathological parameters. Int. J. Cancer 50, 528-532.
41. USMANI, K., KHANUM, A., AFZAL, H., and AHMAD, N. (1996). Breast carcinoma in Pakistani women. J. Environ. Pathol. Toxicol. Oncol. 15, 251-253.
42. WESTON, A., PERRIN, L.S., FORRESTER, K., HOOVER, R.N., TRUMP, B.F., HARRIS, C.C., and CAPORASO, N.E. (1992). Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol. Biomarkers Prev. 6, 481-183.